key: cord-0725859-rrtg908d
authors: Mongkonsritragoon, Wimwipa; Prueksapraoprong, Chattip; Kewcharoen, Jakrin; Tokavanich, Nithi; Prasitlumkum, Narut; Huang, Jenny; Poowuttikul, Pavadee
title: Prevalence and Risk associated with Asthma in Children hospitalized with SARS-CoV-2: A Meta-analysis and Systematic review
date: 2022-02-02
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2021.12.044
sha: babc49cbc742709ba6b46b6ae826647aa3f667b3
doc_id: 725859
cord_uid: rrtg908d

nan

Children appear to be less affected by severe acute respiratory syndrome coronavirus 2 24 (SARS-CoV-2) infection than adults. They present with milder symptoms and develop less severe 25 complications. Asthma has been suggested as one of the risk factors for moderate to severe SARS-26

CoV-2 infection in adults by the Centers of Disease Control and Prevention (CDC), despite 27 heterogeneous results from many studies. It is unclear if children with asthma are at risk for severe 28 children, identifying risk factors for severe SARS-CoV-2 infection in the pediatric population is still 30 important. 31

We performed a meta-analysis to evaluate the prevalence of asthma in pediatric patients 32 hospitalized with SARS-CoV-2 infection and to examine the association between asthma and the risk 33 of hospitalization. We comprehensively searched MEDLINE, EMBASE, and Cochrane Database from 34 inception to March 2021. The systematic literature review was undertaken independently by two 35 investigators (W.M. and N.T.), applying a search approach that incorporated the terms of "COVID 36 19" OR "SARS-CoV-2" combined with the term "Asthma" AND "Children" OR "Pediatric". Eligible 37 studies were either prospective or retrospective observational studies (cohort, case-control, or 38 cross-sectional studies) and randomized studies of any sample size that reported pediatric patients 39 hospitalized for SARS-CoV-2 infection with the diagnosis of asthma. Patients hospitalized in any 40 inpatient pediatric unit (critical care, acute care, and wards) were included. Case reports were 41 excluded. 42 A total of 267 eligible studies were identified using this search strategy. After excluding 43 duplicate articles, case reports, correspondences, review articles, in vitro studies, adult patients, and 44 animal studies, 47 articles met inclusion criteria for full-length review. Out of the 47 articles, 38 45 studies were excluded due lack of interest outcome. The remaining 9 studies included in the analysis 46 were all observational studies. A total of 1,193 pediatric patients were included in these studies(1-9). 47

The details of each study included in the analysis were shown in Table 1 The prevalence of asthma in children hospitalized with SARS-CoV-2 50

The pooled estimated prevalence of asthma in children hospitalized for SARS-CoV-2 infection was 51 19% (95% CI 13-26%, I 2 = 86%) as shown in Figure 1 . The highest prevalence of asthma was 49%, 52 number of children hospitalized with SARS-CoV-2 infection was 805. Of these children, 145 (18%) 54 had asthma. 55

Place Forest plot 1 about here 56

Association between SARS-CoV-2 and hospitalization risks 57

Only 5 of 9 studies had the available data to analyze the impact of asthma on hospitalization 58 risk among children with SARS-CoV-2 infection. The pool estimated odds ratio was 0.79 (95% CI 0.25-59 2.46, I 2 = 83%, P<0.59) as shown in Figure E1 . Our study demonstrated that around 19% of children hospitalized for SARS-CoV-2infection 68 had asthma (calculated with random effect model). However, there was high heterogeneity across 69 the studies with I 2 = 86%. One explanation for the high heterogeneity could be the differing asthma 70 prevalence rate in each study population. Secondly, the difference in the admission criteria for 71 hospitalization in children with SARS-CoV-2 infection between locations could also lead to high 72 heterogeneity. The sensitivity analysis was conducted by omitting one study at a time. The 73 heterogeneity decreased to I 2 = 19.3% and the prevalence of children with asthma who were 74 al. This finding confirmed our hypothesis mentioned above. 76

We demonstrated that asthma is not a risk factor for hospitalization in children with SARS-77

CoV-2 infection. In our meta-analysis, children with asthma did not experience higher severity of 78 SARS-CoV-2 infection. Furthermore, children with asthma and SARS-CoV-2 infection were not at risk 79 for critical care admission. 80

The findings of our analysis may be explained by an association between the COVID-19 viral 81 particle and the angiotensin converting enzyme 2 (ACE 2) receptors which the viral particles attach 82 to enter human cells. Patients with asthma have been shown to have decreased ACE-2 receptor 83 gene expression compared to healthy controls, which may be the protective factor for an individual 84 with asthma. (1) 85 There were several limitations in our study. First, all the studies in our meta-analysis were 86 observational studies, therefore, residual biases are inevitable. Secondly, there were differences in 87 the cutoff age of pediatric patients in each study. Furthermore, one of the studies (Beken,(1)) was 88 less reliable for analysis as 80% of the included patients were female while the majority of children 89 with asthma are male. Thirdly, most of the included studies did not mention how asthma was 90 diagnosed. Lastly, the lack of covariates adjustment of important factors, such as severity of asthma, 91 treatment of asthma, asthma phenotypes, comorbid diseases and a lack of specific criteria for 92 hospitalization and critical care admission would lead to the inclusion of a heterogeneous group of 93 pediatric patients which might affect the overall analysis. 94

Asthma does not appear to be a risk factor for hospitalization or critical care admission due 96 to SARS-CoV-2 infection in children. Further studies and detailed analyses should be performed to 97 confirm this conclusion due to the significant heterogeneity in our analysis. Figure E1 . Forest plot represented the association of asthma and risk of hospitalization in pediatric patients infected with SARS-COV 2 infection Square data markers represent odd ratio (HR), and horizontal line represent the 95% confidence intervals (CIs) with marker size reflecting the statistical weight of study. A diamond data marker represents odd ratio and 95% confidence interval. Figure E2 . Forest plot represented the association of asthma and risk of critical care admission in pediatric patients hospitalized with SARS-COV 2 infection Square data markers represent odd ratio (HR), and horizontal line represent the 95% confidence intervals (CIs) with marker size reflecting the statistical weight of study. A diamond data marker represents odd ratio and 95% confidence interval. 

Asthma and allergic diseases are not 102 risk factors for hospitalization in children with coronavirus disease 2019

Clinical 105 Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with 106

Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City

Severe Coronavirus Disease-109 2019 in Children and Young Adults in the Washington, DC, Metropolitan Region

Covid-19 in Children and Young 112

United Arab Emirates-a Retrospective Cross-Sectional Study. Front Pediatr

Prevalence of asthma 115 in hospitalized and non-hospitalized children with COVID-19

Risk Factors for Severe 117 COVID-19 in Children

COVID-19 in 119 children with underlying chronic respiratory diseases: survey results from 174 centres

COVID-19 hospitalised patients in Switzerland

Characteristics 124 of Hospitalized Children With SARS-CoV-2 in the New York City Metropolitan Area